BAJAJ BROKING
Fosun Pharma will reduce its stake in Gland Pharma by selling 5% for $172 million. The sale price is set at ₹1,750 per share, at a 4.9% discount. Fosun's stake will decrease from 58% to approximately 53.3%. Further sales are anticipated.
Fosun Pharma Industrial Pte, a subsidiary of Shanghai Fosun Pharmaceutical Group, is set to decrease its ownership in India’s Gland Pharma Ltd.
The reduction comes through block deals after failing to sell the stake in a single transaction. Fosun Pharma aims to sell 5% of Gland Pharma, amounting to about $172 million.
The terms of the deal reveal that Fosun Pharma will offer 8.2 million shares at a floor price of ₹1,750 per share, which represents a 4.9% discount compared to the last closing price of ₹1,839.
UBS is managing the deal, expected to decrease Fosun’s stake from 58% to approximately 53.3%.
Exlpore:Gland Pharma Limited Share Price
Fosun Pharma plans additional block sales in the coming months to strengthen its balance sheet, unless buyout firms present a compelling offer.
High valuation expectations from Fosun have reportedly hindered potential sales to private equity firms.
Fosun Pharma originally acquired a 74% stake in Gland Pharma in 2017 for about $1.1 billion from a group including KKR & Co.
Over the past year, Gland Pharma’s shares have risen by 82%, despite being over 55% lower than their 2021 peak.
This block sale marks the second major reduction in Fosun Pharma's stake in Gland Pharma following a successful IPO in November 2020, which raised ₹6,479 crore, including an offer for sale worth ₹5,229 crore by Fosun.
The IPO decreased Fosun’s holding from 75% to 58.36%. As of a recent BSE filing, Fosun Pharma’s stake stood at 57.86%.
Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.
This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For All Disclaimers Click Here: https://bit.ly/3Tcsfuc
Share this article:
Mahindra & Mahindra Raises Fy25 Tractor Growth Forecast Amid Strong Q2 Results
08 Nov, 2024 | 3 Min. read
Tata Power Partners with Noida Airport for ₹550 Cr Renewable Energy Project
08 Nov, 2024 | 3 Min. read
MOIL Achieves Record October Production with 1.47 Lakh Tonnes, Up 32% YoY
08 Nov, 2024 | 2 Min. read
Commodities Market Today | WTI, Brent Crude, Gold, and Silver See Gains in Market Prices
08 Nov, 2024 | 1 Min. read
Share Market Today | Gift Nifty Hints At Flat Start; Markets In Range-Bound Trend
08 Nov, 2024 | 4 Min. read
Fed Cuts Rate by 25 Bps to 4.5-4.75% to Support Cooling Economy
08 Nov, 2024 | 2 Min. read
Gold Rate Today | Gold Rises 1.5% To $2,715.30, Silver Gains 2.5% To $32.11
08 Nov, 2024 | 2 Min. read
Nerolac Paints Q2 Results FY24-25 Highlights
07 Nov, 2024 | 2 Min. read
Trent Q2 Results FY24-25 Highlights
07 Nov, 2024 | 2 Min. read
RVNL Secures ₹5,000 Cr BSNL Project as Lowest Bidder
07 Nov, 2024 | 2 Min. read
MSCI November 2024 Review: New Additions Announced
07 Nov, 2024 | 2 Min. read
Commodities Market Today | Crude Oil, Gold, and Silver Prices Decline in Latest Drop
07 Nov, 2024 | 1 Min. read
RBI Launches ULI: Transforming Loan Access
August 27, 2024 | 4 Min. read
Textile Sector in India
September 20, 2024 | 5 Min. read
List of IPOs with DRHPs Filed
November 30, 2023 | 3 Min. read
Aditya Birla Group
September 28, 2023 | 10 Min. read
Bajaj Housing Finance Ltd IPO: Things Smart Investors Need to Know
September 05, 2024 | 4 Min. read
Budget Stock Ideas 2024-2025 | Stocks to Buy Today
July 24, 2024 | 4 Min. read
IPO Eligibility Criteria : Full Details
March 15, 2024 | 6 Min. read
What Is the Lock-In Period in IPOs?
October 18, 2023 | 6 Min. read
Godfrey Phillips Announces 2:1 Bonus Shares
September 16, 2024 | 7 Min. read
Jindal Group- A Comprehensive Analysis
September 27, 2024 | 7 Min. read
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading